Log in
Enquire now
‌

US Patent 10577416 Mica binding agents

Patent 10577416 was granted and assigned to Innate Pharma on March, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Innate Pharma
Innate Pharma
0
Current Assignee
Innate Pharma
Innate Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105774160
Patent Inventor Names
Ivan Perrot0
Cecile Bonnafous0
Laurent Gauthier0
Mathieu Blery0
Date of Patent
March 3, 2020
0
Patent Application Number
143772740
Date Filed
February 7, 2013
0
Patent Citations Received
‌
US Patent 12065493 Anti-MICA/B antibodies that block MICA/B shedding and methods of use
0
‌
US Patent 10736963 Methods for detecting tissue infiltrating NK cells
Patent Primary Examiner
‌
G. R. Ewoldt
0
Patent abstract

The present invention relates to methods for the treatment of disorders mediated by MICA-expressing cells using antibodies, antibody fragments, and derivatives thereof that specifically bind MICA. The invention also relates to antibodies; cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; and pharmaceutical compositions comprising the same.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10577416 Mica binding agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us